Delgado, E., & Kiani, S. (2020). A CRISPR Odyssey into Cancer Immunotherapy. CRISPR J, 3(2), 73-75.Mary Ann Liebert. doi: 10.1089/crispr.2020.29090.ede.
Ferdosi, S.R., Ewaisha, R., Moghadam, F., Krishna, S., Park, J.G., Ebrahimkhani, M.R., Kiani, S., & Anderson, K.S. (2019). Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes. Nat Commun, 10(1), 1842.Springer Nature. doi: 10.1038/s41467-019-09693-x.
Pineda, M., Lear, A., Collins, J.P., & Kiani, S. (2019). Safe CRISPR: Challenges and Possible Solutions. Trends Biotechnol, 37(4), 389-401.Elsevier. doi: 10.1016/j.tibtech.2018.09.010.
Yeo, N.C., Chavez, A., Lance-Byrne, A., Chan, Y., Menn, D., Milanova, D., Kuo, C.C., Guo, X., Sharma, S., Tung, A., Cecchi, R.J., Tuttle, M., Pradhan, S., Lim, E.T., Davidsohn, N., Ebrahimkhani, M.R., Collins, J.J., Lewis, N.E., Kiani, S., & Church, G.M. (2018). An enhanced CRISPR repressor for targeted mammalian gene regulation. Nat Methods, 15(8), 611-616.Springer Nature. doi: 10.1038/s41592-018-0048-5.
Kiani, S., Chavez, A., Tuttle, M., Hall, R.N., Chari, R., Ter-Ovanesyan, D., Qian, J., Pruitt, B.W., Beal, J., Vora, S., Buchthal, J., Kowal, E.J.K., Ebrahimkhani, M.R., Collins, J.J., Weiss, R., & Church, G. (2015). Cas9 gRNA engineering for genome editing, activation and repression. Nat Methods, 12(11), 1051-1054.Springer Nature. doi: 10.1038/nmeth.3580.